MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fonc.2023.1188371

Медицинская библиотека · Frontiers in oncology · 2023

The role of TSC2 in breast cancer: a literature review.

Zhu Qiao-Yan, He Zhe-Min, Cao Wen-Ming, Li Bei

СтатьяОбзорПеревод в очереди

Аннотация

TSC2 is a tumor suppressor gene as well as a disease-causing gene for autosomal dominant disorder tuberous sclerosis complex (TSC). Research has found that some tumor tissues have lower TSC2 expression levels than normal tissues. Furthermore, low expression of TSC2 is associated with poor prognosis in breast cancer. TSC2 acts as a convergence point of a complex network of signaling pathways and receives signals from the PI3K, AMPK, MAPK, and WNT pathways. It also regulates cellular metabolism and autophagy through inhibition of a mechanistic target of rapamycin complex, which are processes relevant to the progression, treatment, and prognosis of breast cancer. In-depth study of TSC2 functions provides significant guidance for clinical applications in breast cancer, including improving the treatment efficacy, overcoming drug resistance, and predicting prognosis. In this review, protein structure and biological functions of TSC2 were described and recent advances in TSC2 research in different molecular subtypes of breast cancer were summarized.

Для цитирования: Zhu Qiao-Yan, He Zhe-Min, Cao Wen-Ming, Li Bei. The role of TSC2 in breast cancer: a literature review.. Frontiers in oncology. 2023. DOI: 10.3389/fonc.2023.1188371.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.